Integrating quality into the cycle of therapeutic development.

[1]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[2]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[3]  D. DeMets,et al.  Principles From Clinical Trials Relevant to Clinical Practice: Part II , 2002, Circulation.

[4]  Robert M Califf,et al.  Lessons learned from recent cardiovascular clinical trials: Part II. , 2002, Circulation.

[5]  D. Mark,et al.  Medical economics and the assessment of value in cardiovascular medicine: Part I. , 2002, Circulation.

[6]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[7]  P. Serruys,et al.  210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions , 2002 .

[8]  A. Detsky,et al.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry. , 2002, JAMA.

[9]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[10]  D. DeMets,et al.  Principles from clinical trials relevant to clinical practice: Part I. , 2002, Circulation.

[11]  Robert M Califf,et al.  Lessons learned from recent cardiovascular clinical trials: Part I. , 2002, Circulation.

[12]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[13]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[14]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[15]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[16]  D. DeMets,et al.  Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. , 2001, Controlled clinical trials.

[17]  M. Simoons.  Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.

[18]  J J Allison,et al.  Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. , 2001, JAMA.

[19]  S. Shortell,et al.  Improving the quality of health care in the United Kingdom and the United States: a framework for change. , 2001, The Milbank quarterly.

[20]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[21]  H. Krumholz,et al.  Can practice guidelines be transported effectively to different settings? Results from a multicenter interventional study. , 2001, The Joint Commission journal on quality improvement.

[22]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[23]  G. Specchia,et al.  Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. , 2000, European heart journal.

[24]  Rezulin to be withdrawn from the market. , 2000, Diabetes technology & therapeutics.

[25]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[26]  A. Garson.  President's page: integrating the internet into your practice. , 1999, Journal of the American College of Cardiology.

[27]  D L Sackett,et al.  Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect. , 1999, JAMA.

[28]  A. Garson.  President's page: The Great Circle: a target for better patient care. , 1999, Journal of the American College of Cardiology.

[29]  C. Furberg.  Natural statins and stroke risk. , 1999, Circulation.

[30]  E. McGlynn,et al.  How good is the quality of health care in the United States? , 1998, The Milbank quarterly.

[31]  H. Krumholz,et al.  Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. , 1998, JAMA.

[32]  D. DeMets,et al.  Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.

[33]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[34]  S. Ellenberg.  Surrogate end points in clinical trials. , 1991, BMJ.

[35]  K N Lohr,et al.  A strategy for quality assurance in Medicare. , 1990, The New England journal of medicine.

[36]  F. Harrell,et al.  Clinical judgment and therapeutic decision making. , 1990, Journal of the American College of Cardiology.

[37]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.